Paris, May 31, 2021. For more information about this press release, please contact Sabine Chestier media contact for Curium: sabine.chestier@curiumpharma.com.
About IASON
IASON, founded in 1994, is an independent Austrian company IASON is a leading specialist in Europe for the development, production and distribution of radiopharmaceuticals for positron-emission-tomography (PET). With its innovation culture and highly trained employees, IASON helps thousands of patients afflicted with cancer to live longer and better lives.
The company operates two state-of-the-art PET radiopharmaceutical manufacturing facilities in Austria (Linz and Klagenfurt) and supplies specialized PET products to private and public hospitals across Austria and Central Europe.
